Found: 42
Select item for more details and to access through your institution.
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 429, doi. 10.1007/s10549-018-5009-2
- By:
- Publication type:
- Article
Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 8, p. 2435, doi. 10.1245/s10434-019-07388-7
- By:
- Publication type:
- Article
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high‐risk characteristics by molecular expression profiling.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 3, p. 175, doi. 10.1002/gcc.22716
- By:
- Publication type:
- Article
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920973130
- By:
- Publication type:
- Article
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0168-9
- By:
- Publication type:
- Article
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 573, doi. 10.1007/s10549-017-4358-6
- By:
- Publication type:
- Article
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 150, n. 2, p. 279, doi. 10.1007/s10549-015-3310-x
- By:
- Publication type:
- Article
Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 3, p. 643, doi. 10.1007/s10549-011-1377-6
- By:
- Publication type:
- Article
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8581, doi. 10.1002/cam4.4376
- By:
- Publication type:
- Article
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.
- Published in:
- Breast Care, 2021, v. 16, n. 5, p. 475, doi. 10.1159/000512416
- By:
- Publication type:
- Article
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
- Published in:
- Breast Care, 2021, v. 16, n. 1, p. 50, doi. 10.1159/000506622
- By:
- Publication type:
- Article
Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.
- Published in:
- Breast Care, 2019, v. 14, n. 3, p. 165, doi. 10.1159/000490040
- By:
- Publication type:
- Article
Genomic Profiling in Luminal Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast Cancers.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early...
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer
- Published in:
- Breast Care, 2013, v. 8, n. 2, p. 110, doi. 10.1159/000350777
- By:
- Publication type:
- Article
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer.
- Published in:
- Breast Care, 2010, v. 5, n. 6, p. 401, doi. 10.1159/000322661
- By:
- Publication type:
- Article
Perspectives: Other ErbB2-Targeted Therapies.
- Published in:
- Breast Care, 2010, v. 5, p. 25, doi. 10.1159/000285779
- By:
- Publication type:
- Article
Adjuvant Chemotherapy of Breast Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Question & Answer
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).
- Published in:
- Breast Care, 2009, v. 4, n. 2, p. 109, doi. 10.1159/000212164
- By:
- Publication type:
- Article
Adjuvant and Neoadjuvant Therapy with Lapatinib in ErbB2-Overexpressing Breast Cancer.
- Published in:
- Breast Care, 2008, v. 3, p. 17, doi. 10.1159/000119747
- By:
- Publication type:
- Article
Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer.
- Published in:
- Breast Care, 2006, v. 1, n. 4, p. 252, doi. 10.1159/000094891
- By:
- Publication type:
- Article
Breast Cancer Surgery Oncological Aspects.
- Published in:
- Breast Care, 2006, v. 1, n. 4, p. 229, doi. 10.1159/000095125
- By:
- Publication type:
- Article
Einsatz von Taxanen in der Therapie des Mammakarzinoms.
- Published in:
- Breast Care, 2006, v. 1, n. 3, p. 189, doi. 10.1159/000093797
- By:
- Publication type:
- Article
Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 6, p. 1433, doi. 10.1002/ijc.23628
- By:
- Publication type:
- Article
Trastuzumab emtansine (T-DM1) renders HER2<sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aac4925
- By:
- Publication type:
- Article
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 1, p. 262, doi. 10.1002/ijc.32488
- By:
- Publication type:
- Article
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 882, doi. 10.1002/ijc.30078
- By:
- Publication type:
- Article
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- Published in:
- Trials, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1745-6215-14-261
- By:
- Publication type:
- Article
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1715, doi. 10.1038/s41416-021-01690-6
- By:
- Publication type:
- Article
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4847, doi. 10.1002/cncr.33104
- By:
- Publication type:
- Article
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 14, p. 1018
- By:
- Publication type:
- Article
Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 6, p. 826, doi. 10.1007/s12282-019-00990-3
- By:
- Publication type:
- Article